Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Structuur eiwit hepatitis C-virus ontrafeld
okt 2022 | Hepatitis, Hepatologie, Vaccinatie, Virale infecties